Compounds > 1,2,3,4-tetrahydroquinoline
Page last updated: 2024-08-25

1,2,3,4-tetrahydroquinoline and urea

1,2,3,4-tetrahydroquinoline has been researched along with urea in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Bayburt, EK; Bianchi, BR; Daanen, JF; Faltynek, CR; Gomtsyan, A; Honore, P; Joshi, S; Koenig, JR; Latshaw, SP; Lee, CH; Marsh, KC; McDonald, HA; Schmidt, RG; Zhong, C1
Abuskhuna, S; Benbrook, DM; Bhandari, D; Bunce, RA; Darrell Berlin, K; Gnanasekaran, KK; Mashayekhi, M; Pouland, T; Zhou, DH1
Baska, F; Bata, I; Bozó, É; Cselenyák, A; Domány-Kovács, K; Kordás, KS; Kurkó, D; Makó, A; Mohácsi, R; Szántó, G1

Other Studies

3 other study(ies) available for 1,2,3,4-tetrahydroquinoline and urea

ArticleYear
Chroman and tetrahydroquinoline ureas as potent TRPV1 antagonists.
    Bioorganic & medicinal chemistry letters, 2011, Mar-01, Volume: 21, Issue:5

    Topics: Chromans; Humans; Inhibitory Concentration 50; Molecular Structure; Quinolines; TRPV Cation Channels; Urea

2011
Tetrahydroquinoline units in flexible heteroarotinoids (Flex-Hets) convey anti-cancer properties in A2780 ovarian cancer cells.
    Bioorganic & medicinal chemistry, 2020, 01-01, Volume: 28, Issue:1

    Topics: Antineoplastic Agents; Binding Sites; Cell Line, Tumor; Cell Proliferation; Chromans; Female; Humans; Molecular Docking Simulation; Ovarian Neoplasms; Quinolines; Structure-Activity Relationship; Thiones; Urea

2020
New V1a receptor antagonist. Part 1. Synthesis and SAR development of urea derivatives.
    Bioorganic & medicinal chemistry letters, 2020, 09-15, Volume: 30, Issue:18

    Topics: Antidiuretic Hormone Receptor Antagonists; High-Throughput Screening Assays; Humans; Inhibitory Concentration 50; Piperazine; Protein Binding; Pyridines; Quinolines; Receptors, Vasopressin; Social Behavior Disorders; Structure-Activity Relationship; Urea

2020